OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Bradyarrhythmia reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,620 reports · 57 co-occurring drugs

As of the last recalculation, Bradyarrhythmia appears in 1,620 FAERS reports alongside 57 co-occurring drug terms. The strongest observed disproportionality signal is ITRACONAZOLE (PRR 37.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Itraconazole3337.037.1
Digoxin18136.436.4
Cladribine1925.725.7
Bisoprolol Fumarate19621.021.0
Terazosin Hydrochloride1318.919.0
Donepezil Hydrochloride4817.317.3
Atropine1117.217.2
Memantine1817.117.1
Memantine Hydrochloride1817.117.1
Bupivacaine1216.616.6
Propofol4516.216.3
Amphotericin B1515.515.5
Torsemide3815.115.1
Atropine Sulfate1214.414.4
Basiliximab1314.314.3
Ticagrelor3414.014.0
Dronedarone1012.712.7
Nebivolol1512.212.2
Clarithromycin3212.212.2
Phenytoin1911.811.8
Timolol Maleate911.711.7
Diltiazem Hydrochloride Extended-Release Tablets1011.411.4
Enalapril Maleate2111.011.0
Ramipril919.99.9
Rocuronium Bromide99.99.9
Dorzolamide Hydrochloride And Timolol Maleate69.89.8
Spironolactone1019.89.8
Doxazosin Mesylate269.49.4
Amiodarone Hydrochloride89.29.2
Enalapril389.09.0
Mycophenilic Acid148.78.8
Doxazosin188.38.4
Warfarin Sodium298.28.2
Norepinephrine67.27.2
Insulin Human227.27.2
Lamivudine Oral147.27.2
Dabigatran Etexilate427.17.1
Agalsidase Beta57.07.0
Insulin Glulisine56.36.3
Lacosamide186.36.3
Sevoflurane46.26.2
Rivastigmine96.26.2
Levetiracetam In Sodium Chloride366.16.1
Levetiracetam Oral366.16.1
Levetiracetam Injection366.16.1
Alteplase76.06.0
Ethyl Alcohol125.75.7
Isopropyl Alcohol145.45.4
Baricitinib45.35.3
Dabigatran Etexilate Mesylate295.25.2
Patiromer54.74.7
Tolvaptan54.44.4
Tafamidis44.44.4
Alcohol124.04.0
Ranolazine33.73.7
Paricalcitol43.63.6
Remdesivir32.92.9

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.